from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2837c/-

LFCtreatmentdescriptionclass of inhibitor

-0.103

Amikacinug/mL Amikacintranslation

-0.614

Cap5-10ug/mL Capreomycintranslation

-1.426

Rox10-50 ug/mL Roxithromycintranslation

1.307

SM2-5 ug/mL Streptomycintranslation

-0.066

Tet5-10 ug/mL Tetracyclinetranslation

1.008

Rif0.2-5ug/mL Rifampicintranscription

0.845

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.018

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.186

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.036

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.437

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.690

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.924

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.597

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.380

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.922

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.564

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.568

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.272

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.543

KCN5-20 ug/mL Potassium cyaniderespiration

-0.321

NaN30.2-2 mM Sodium aziderespiration

0.107

Nigericin50 uM Nigericinrespiration

0.261

TRC10-150 ug/mL Triclosanrespiration

-1.572

TRZ10-25 ug/mL Thioridazinerespiration

2.391

Valinomycin0.5-10 uM Valinomycinrespiration

-1.779

ZnSO42 mM ZnSO4respiration

-0.034

menadione6-10 ug/mL Menadionerespiration

0.202

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.183

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.000

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.696

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.705

NRP_1Non-replicating persistence stage 1dosRassociated

0.129

Amp0.2mg/mL AmpicillincellWall

0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.449

Cerulenin0.32-5 ug/mL CerulenincellWall

0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.424

EMB10-20 ug/mL EthambutolcellWall

0.215

Eta12-40 ug/mL EthionamidecellWall

0.512

INH0.2-0.4 ug/mL IsoniazidcellWall

0.367

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.063

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.973

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.501

BZA0.12 mg/mL BenzamidearomaticAmides

0.206

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.187

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.025

H2O24 mM hydrogen peroxideDNAdamaging

-0.266

Levo10 ug/mL LevofloxacinDNAdamaging

0.542

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.495

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.101

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.353

UVUV-irradiationDNAdamaging

-0.227

ARP41-4 ug/mL Antitubercular compound ARP4?

0.176

Antimycin12.5-50 ug/mL Antimycin A?

-0.718

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.290

PA_110-50 ug/mL Antitubercular compound PA-1?

0.510

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.610

PA8240.2-2 ug/mL PA-824?

-0.162

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.350

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.426

Verapamil50 uM Verapamil?

-0.552

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.305

methoxatin10-20 ug/mL Methoxatin?